Abstract 4359116: Genome Wide Association Study Identifies Loci Associated with Pulmonary Pressure

V Vineet Agrawal (Vanderbilt University Medical Cente, Brentwood, Tennessee, United States) Q Qin Hui J Jonah Garry (Vanderbilt Univ Medical Center, Nashville, Tennessee, United States) S Suman Kundu J James West (Vanderbilt University Medical Cente, Nashville, Tennessee, United States) J Jonathan Mosley (Univesity of Texas Southwestern, Dallas, Texas, United States) J Joshua Kepler (VA PROVIDENCE HEALTHCARE, BROWN U., Providence, Rhode Island, United States) M Matthew Freiberg (Vanderbilt Univ Medical Center, Nashville, Tennessee, United States) J Jacob Joseph Y Yan Sun E Evan Brittain (Vanderbilt University Medical Cente, Nashville, Tennessee, United States)

Abstract

Background: Rare Mendelian drivers of pulmonary arterial hypertension (PAH) have been identified, but the contributions of common genetic variation to pulmonary pressure in other causes of pulmonary hypertension (PH) are not well understood. Research Questions: To identify common genetic variants associated with estimated pulmonary pressure in two large patient populations undergoing clinically indicated echocardiography (echo). Methods: Echo estimates of pulmonary artery systolic pressure (ePASP) were extracted from the Million Veterans Program (MVP) and Vanderbilt’s BioVU using a published algorithm. Genome wide association study (GWAS) and trans-ancestral meta-analysis of highest measured ePASP were performed using genomic data from MVP participants with replication of lead SNPs in BioVU. Results: Among 158,739 MVP participants (94% male; 72% European, 20% African, 7% Hispanic, 1% Asian ancestry), the median age was 67 (IQR 61-73), median BMI was 29.2 (IQR 25.8-33.4), and median ePASP was 34.9 (IQR 27.5 – 43.2) mmHg. Trans-ancestry GWAS meta-analysis in 148,464 MVP participants identified genomic loci associated with ePASP at genome-wide significance (5x10 -8 ) near KCNK3, SCN10, CDKN1A, TMEM8C, BDNF, and FTO genes (Figure 1). Phenome wide association studies of lead SNPs identified PAH, cardiac diseases, and metabolic disorders as sharing genetic risk for ePASP. The lead SNP near KCNK3, rs1275985 (MAF 47%), remained significant when GWAS was conducted using tricuspid regurgitation velocity (0.018 + 0.006 mmHg/allele) and in a case-control analysis using ePASP > 40 as the threshold for PH (0.056 + 0.018 log OR/allele). Replication of the lead SNPs in the BioVU cohort confirmed rs1275985 as the only SNP significantly associated with ePASP (p < 0.05/7), which persisted in case-control analysis of PH in BioVU at various thresholds (Figure 2) and when stratified comorbid heart failure (Figure 3). Conclusions: We conducted the largest GWAS of ePASP to date with replication of significant SNPs near KCNK3 in a second cohort. KCNK3 mutations have been implicated in Mendelian causes of PAH. This study suggests that genetic variation near KCNK3 may broadly affect PH risk across different subtypes of PH as well.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

V

Vineet Agrawal

Vanderbilt University Medical Cente, Brentwood, Tennessee, United States

Q

Qin Hui

J

Jonah Garry

Vanderbilt Univ Medical Center, Nashville, Tennessee, United States

S

Suman Kundu

J

James West

Vanderbilt University Medical Cente, Nashville, Tennessee, United States

J

Jonathan Mosley

Univesity of Texas Southwestern, Dallas, Texas, United States

J

Joshua Kepler

VA PROVIDENCE HEALTHCARE, BROWN U., Providence, Rhode Island, United States

M

Matthew Freiberg

Vanderbilt Univ Medical Center, Nashville, Tennessee, United States

J

Jacob Joseph

Y

Yan Sun

E

Evan Brittain

Vanderbilt University Medical Cente, Nashville, Tennessee, United States